HICP - Tea, mate and other plant-derived products for infusion (ND) in Lithuania
Lithuania: HICP - Tea, mate and other plant-derived products for infusion (ND) was 1.89 in 2026. ▼ Falling
HICP - Tea, mate and other plant-derived products for infusion (ND) in Lithuania, 1996–2026
Source: European Central Bank.
Analysis
Lithuania recorded 1.89 for hicp - tea, mate and other plant-derived products for infusion (nd) in 2026.
The figure is up 6.2% on the previous year and down 20.6% over ten years.
Over the whole period, hicp - tea, mate and other plant-derived products for infusion (nd) in Lithuania peaked at 3.46 in 2001 and was at its lowest, 1.42, in 1996.
Lithuania ranks 3rd of 27 countries on this measure, in the top 10%.
The long-run direction has been consistently falling across the 31 years of available data.
HICP - Tea, mate and other plant-derived products for infusion (ND) in Lithuania, year by year
| Year | Value | Change |
|---|---|---|
| 1996 | 1.42 | — |
| 1997 | 1.47 | +3.5% |
| 1998 | 1.42 | -3.4% |
| 1999 | 2.89 | +103.5% |
| 2000 | 3.26 | +12.8% |
| 2001 | 3.46 | +6.1% |
| 2002 | 2.95 | -14.7% |
| 2003 | 2.91 | -1.4% |
| 2004 | 2.78 | -4.5% |
| 2005 | 2.54 | -8.6% |
| 2006 | 2.04 | -19.7% |
| 2007 | 2.14 | +4.9% |
| 2008 | 2.08 | -2.8% |
| 2009 | 2.12 | +1.9% |
| 2010 | 2.09 | -1.4% |
| 2011 | 2.18 | +4.3% |
| 2012 | 2.05 | -6.0% |
| 2013 | 1.83 | -10.7% |
| 2014 | 2.26 | +23.5% |
| 2015 | 2.19 | -3.1% |
| 2016 | 2.38 | +8.7% |
| 2017 | 2.46 | +3.4% |
| 2018 | 2 | -18.7% |
| 2019 | 2.05 | +2.5% |
| 2020 | 2.14 | +4.4% |
| 2021 | 2.3 | +7.5% |
| 2022 | 2.23 | -3.0% |
| 2023 | 1.95 | -12.6% |
| 2024 | 1.9 | -2.6% |
| 2025 | 1.78 | -6.3% |
| 2026 | 1.89 | +6.2% |
Lithuania compared with similar countries
- Lithuania's 1.89 is above the median for Europe & Central Asia, which is 0.92, 2.1× the median. (26 countries reporting)
- Lithuania's 1.89 is above the median for high income countries, which is 0.92, 2.1× the median. (27 countries reporting)
Biggest year-on-year movements
Years where HICP - Tea, mate and other plant-derived products for infusion (ND) in Lithuania changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1999 | +103.5% | 1.42 | 2.89 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 1.8 | 1.42 | 2.89 | 4 |
| 2000s | 2.63 | 2.04 | 3.46 | 10 |
| 2010s | 2.15 | 1.83 | 2.46 | 10 |
| 2020s | 2.03 | 1.78 | 2.3 | 7 |
Countries ranked near Lithuania
More economy & growth data for Lithuania
- Foreign direct investment, net outflows (BoP, current US$), gaps 127.67 million BoP, current US$ (2025)
- Foreign direct investment, net outflows (BoP, current US$), per unit 0.0013 BoP, current US$ per US$ of GDP (2025)
- Foreign direct investment, net outflows (BoP, current US$), per capita 44.19 BoP, current US$ per person (2025)
- Foreign direct investment, net inflows (BoP, current US$), gaps filled 3.09 billion BoP, current US$ (2025)
- Foreign direct investment, net inflows (BoP, current US$), annual -34.32 % change on previous year (2025)
- Foreign direct investment, net inflows (BoP, current US$), per unit 0.0324 BoP, current US$ per US$ of GDP (2025)
- Foreign direct investment, net inflows (BoP, current US$), per capita 1,069 BoP, current US$ per person (2025)
- Total reserves (includes gold, current US$), annual growth rate -4.7 % change on previous year (2025)
- Total reserves (includes gold, current US$), per unit of GDP 0.0741 includes gold, current US$ per US$ of GDP (2025)
- Total reserves (includes gold, current US$), per capita 2,444 includes gold, current US$ per person (2025)
Frequently asked questions
- What is hicp - tea, mate and other plant-derived products for infusion (nd) in Lithuania?
- Hicp - tea, mate and other plant-derived products for infusion (nd) in Lithuania was 1.89 in 2026, according to European Central Bank.
- What is the highest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Lithuania?
- The highest recorded value was 3.46 in 2001.
- What is the lowest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Lithuania?
- The lowest recorded value was 1.42 in 1996.
- How does Lithuania rank for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Lithuania ranks 3rd out of 27 countries with data for 2026.
- Is hicp - tea, mate and other plant-derived products for infusion (nd) rising or falling in Lithuania?
- Over the last ten years it is down 20.6%. The long-run trend across the full record is falling.
- Where does this Lithuania data come from?
- The figures come from European Central Bank, published as part of HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 31 observations, free to reuse under ECB Terms and Conditions (attribution required).